Lajohn Quigley, MD
Surgery · Amarillo, TXNPI 1609076959
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $10,191 of the $15,908 with a category attached, or 64.1%. 14 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 51.5% of the total. Reporting peaked in 2019 at $5,811 and has fallen 77.9% since, to $1,281 in 2025.
Across 82 payments — averaging $194.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$8K
- Intuitive Surgical$6K
- Stryker$823
- Medical Device Business Services, Inc.$319
- Johnson & Johnson$277
- Baxter Healthcare$118
- plus $419 from 8 others
What the payments were for
- Speaking & faculty fees$1,5009%
- Travel & lodging$10,19164%
- Food & beverage$4,17226%
- Education$450%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 31 | $8,194 |
| Intuitive Surgical | 31 | $5,758 |
| Stryker | 2 | $823 |
| Medical Device Business Services, Inc. | 2 | $319 |
| Johnson & Johnson | 4 | $277 |
| Baxter Healthcare | 2 | $118 |
| Acera Surgical, Inc. | 1 | $108 |
| Smith+Nephew | 3 | $95 |
| Acell, Inc. | 1 | $82 |
| Medtronic | 1 | $67 |
| Kerecis Limited | 1 | $19 |
| AbbVie | 1 | $17 |
| Advanced Respiratory, Inc | 1 | $15 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,378
- BIO-A Tissue Reinforcement$2,299
- SEAMGUARD Bioabsorbable Staple Line Reinforcement$1,931
- DA VINCI SP$1,500
- GORE BIO-A Tissue Reinforcement$1,218
- SEAMGUARD$1,101
- GORE SEAMGUARD Bioabsorbable Staple Line Reinforce$867
- SPY-PHI SYSTEM$442
- ECHELON ENDOPATH$441
- 1688$381
- SYNECOR Biomaterial$141
- VISTASEAL$122
- Restrata Wound Matrix$108
How this compares
$15,908 in reported general payments places this provider in the 80th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 29 | $27,019 |
| Sucralfate | 14 | $825 |
| Pantoprazole Sodium | 40 | $188 |
| Ondansetron OdtOndansetron | 13 | $161 |
Paid to pharmacies, not to this prescriber.
Other surgery in Amarillo
- Bo NeichoyAmarillo$169K
- Matthew SchniederjanAmarillo$92K
- Michael HarkinsTomball$2.7M
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Andy HawthorneRound Rock$843K
- Nancy MarquezAustin$700K
- Sachin KukrejaDallas$640K
- Alejandro EsquivelAustin$631K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.